Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

What Should Bank Of America Corporation Investors Know After 4.76% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline

prnewswire.com
BAC

XTransfer Debuts at Money20/20 USA Accelerate Expansion into Latin American Markets

globenewswire.com
JPM

Levi & Korsinsky Urges Alphabet Inc. (GOOGL) Shareholders to Act Before Lead Plaintiff Deadline December 1, 2026

accessnewswire.com
GOOGL

Securities Fraud Class Action Filed Against Baidu, Inc. (BIDU) - Levi & Korsinsky Reminds Investors of November 13, 2026

accessnewswire.com
BIDU

Levi & Korsinsky Notifies Duolingo, Inc. (DUOL) Shareholders of Class Action Lawsuit and December 7, 2026 Deadline

accessnewswire.com
DUOL

A Secret Weapon in Radiology Management: Novarad Updates More Than 1,000 Imaging Facilities Worldwide in a Matter of Weeks

globenewswire.com
NVDA

Kaplan Fox Alerts Investors of Coastal Financial Corporation (NASDAQ: CCB) to a Pending Securities Class Action – Deadline is December 1, 2026

globenewswire.com
CCB

What's Next for Unicycive Therapeutics, Inc. Shareholders After 39.1% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline

prnewswire.com
UNCY

Brenus Pharma新型体内免疫疗法STC-1010在一线MSS型转移性结直肠癌中显示出安全性并激活T细胞,2例患者实现完全缓解

businesswire.com
BRNS

Brenus Pharma新型體內免疫療法STC-1010在一線MSS型轉移性大腸直腸癌中顯示出安全性並活化T細胞,2例病患實現完全緩解

businesswire.com
BRNS
View all news →